Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GeneDx Holdings Corp.

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Participate in 44th Annual Cowen Health Care Conference
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Preliminary 2023 Financial Results
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Evolution of Executive Leadership Team
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
GeneDx to Participate in Upcoming Investor Conferences in June
From GeneDx Holdings Corp.
Via GlobeNewswire
Tickers WGS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS